This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: upstream therapy

The future of atrial fibrillation: does the answer lie in ablation or anti-arrhythmics?

February 2019 Br J Cardiol 2019;26:31–3 doi:10.5837/bjc.2019.009

The future of atrial fibrillation: does the answer lie in ablation or anti-arrhythmics?

Mark T Mills

Abstract

Dr Mark Mills The question: medicate, or ablate? To medicate (with anti-arrhythmics), or to ablate: that is the question. In the management of atrial fibrillation (AF), the answer, depending on those questioned and the evidence cited, might be one, the other, both, or neither. Anti-arrhythmic drugs, compared with rate-control drugs, confer no prognostic benefit.1 Furthermore, emerging evidence suggests that ablation confers no mortality benefit over drug therapy.2 This equivocality presents a challenge in clinical practice. Here, consideration is given to each of these standpoints, while highlighting gaps in current knowledge and future direc

| Full text
Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now